Key Record Dates
ClinicalTrials.gov Identifier: | NCT04347239 |
---|---|
Brief Title: | Study to Evaluate the Efficacy and Safety of Leronlimab for Patients With Severe or Critical Coronavirus Disease 2019 (COVID-19) |
First Submitted : | April 13, 2020 |
First Submitted that Met QC Criteria : | April 14, 2020 |
First Posted : | April 15, 2020 |
Last Update Submitted that Met QC Criteria : | January 13, 2022 |
Last Update Posted : | January 14, 2022 |